Advanced Flower Capital Inc., the West Palm Beach based real estate investment trust that lends to cannabis operators, has seen its dividend fall 62.4% over the past year, with its payout status now flagged as "Reduced." The company most recently paid a quarterly dividend of $0.05 per share on July 15, 2026, and declared another $0.05 payment on September 15, 2026, with an ex-dividend date of September 30 and payment due October 15. At current prices, the stock yields 5.57%, a decline that first stood out in data tracked on Dividendly, a Madison Labs research site.
The drop in payout marks a steep retreat from where the dividend once stood, and it comes alongside a trailing twelve month payout ratio of 152.66% on an earnings per share basis, meaning the company has been distributing more in dividends than it has generated in net income over that period. For a mortgage REIT, that combination, a shrinking dividend paired with a payout ratio well above 100%, points to a business under pressure to align its distributions with what its loan book is actually earning.
For income focused investors, the shift matters because it changes the character of the position from a steady payer to one whose near term dividend trajectory is uncertain. The stock's own screening profile, which weighs payout sustainability, profitability and valuation, currently scores the shares at 51 out of 100, a middling rank that sits below the threshold typically associated with stronger dividend durability. The dividend also fails three of the four durability checks commonly used to assess payout quality: it has not grown for three consecutive years, its payment record already includes a reduction, and its five year payment history falls well short of the two decades typically sought to demonstrate resilience through a full economic cycle. Taken together, one reading of those figures is that the dividend's near term path depends heavily on how the company's loan portfolio performs from here, though that is an interpretation of the disclosed metrics rather than a company statement or guarantee of future action.
By way of background, Advanced Flower Capital originates senior secured loans to established cannabis companies, often backed by real estate, equipment, licenses or cash flows, a niche created because federal prohibition has kept most traditional banks out of direct cannabis lending. The company was incorporated in 2020 and operated as AFC Gamma before rebranding to Advanced Flower Capital in October 2024. That lending niche has proven volatile industry wide, as state licensed cannabis operators have faced their own pricing pressure, oversupply in some markets and constrained access to capital, all of which can flow through to the credit quality of loans held by lenders like Advanced Flower Capital.
The shares have traded between $2.09 and $4.15 over the past 52 weeks, and closed the most recent session in the $3.49 to $3.57 range on light volume of roughly 35,700 shares. With a market capitalization near $81.9 million and about 22.81 million shares outstanding, the company remains a small cap name within the specialty finance and REIT space, a corner of the market that has drawn scrutiny more broadly as investors weigh loan demand and credit conditions across commercial lenders. That broader attention to loan books and returns has been a recurring theme across the specialty lending sector this year, even as the cannabis lending niche in particular continues to carry the added regulatory overhang common to the industry.
Looking ahead, dividend focused investors are likely to watch whether Advanced Flower Capital's next declarations hold at the reduced $0.05 quarterly level or move again, and whether the payout ratio narrows toward or below 100% as the company's loan portfolio generates income relative to what it distributes. The next ex-dividend date of September 30, 2026, and payment date of October 15, 2026, will offer the first concrete data points on that front. Any commentary from the company itself on portfolio performance or dividend policy, rather than the historical metrics alone, would give a clearer signal of where the payout is headed, and no such guidance has been referenced in the data reviewed here.